124 related articles for article (PubMed ID: 8721844)
1. [Nucleolus organizers in the epithelium of serous ovarian tumors].
Iakovtsova II
Tsitol Genet; 1995; 29(5):38-41. PubMed ID: 8721844
[TBL] [Abstract][Full Text] [Related]
2. [Karyometry of the tumor epitheliocytes in the dysplastic sections of serous tumors and in serous cancers of the ovaries].
Iakovtsova II
Tsitol Genet; 1996; 30(6):12-5. PubMed ID: 9139432
[TBL] [Abstract][Full Text] [Related]
3. Morphometry and digital AgNOR analysis in cytological imprints of benign, borderline and malignant serous ovarian tumours.
Stemberger-Papić S; Stanković T; Vrdoljak-Mozetic D; Versa-Ostojić D; Krasević M; Stifter S; Audy-Jurković S
Cytopathology; 2006 Dec; 17(6):382-9. PubMed ID: 17168922
[TBL] [Abstract][Full Text] [Related]
4. Prognostic importance of the nucleolar organizer region score in ovarian epithelial tumors.
Zergeroğlu S; Aksakal O; Demirtürk F; Gökmen O
Gynecol Obstet Invest; 2001; 51(1):60-3. PubMed ID: 11150878
[TBL] [Abstract][Full Text] [Related]
5. [Morphofunctional features of the nucleoli in glandular hyperplasia and endometrial cancer].
Buchinskaia LG; Polishchuk LZ; Ganina KP
Tsitol Genet; 1992; 26(3):3-7. PubMed ID: 1502729
[TBL] [Abstract][Full Text] [Related]
6. [Morphofunctional characteristics of microvessels in serous tumors of the ovaries].
Mikhaleva LM; Moroz EA; Barkhina TG; Cherniaev AL; Samsonova MV; Solomatina AA
Arkh Patol; 2005; 67(6):28-31. PubMed ID: 16405018
[TBL] [Abstract][Full Text] [Related]
7. Well-differentiated serous neoplasms of the ovary.
Longacre TA; Kempson RL; Hendrickson MR
Pathology (Phila); 1993; 1(2):255-306. PubMed ID: 9420921
[TBL] [Abstract][Full Text] [Related]
8. Metallothionein expression and nuclear size in benign, borderline, and malignant serous ovarian tumours.
Tan Y; Sinniah R; Bay BH; Singh G
J Pathol; 1999 Sep; 189(1):60-5. PubMed ID: 10451489
[TBL] [Abstract][Full Text] [Related]
9. [Prognostic significance of cellular DNA content and AgNOR count in ovarian cystadenoma].
Lu XL; Yi WM; Wang LF
Ai Zheng; 2003 Jan; 22(1):62-5. PubMed ID: 12561439
[TBL] [Abstract][Full Text] [Related]
10. Cytopathology of serous neoplasia of the ovary and the peritoneum: differential diagnosis from mesothelial proliferations.
Pisharodi LR; Bedrossian CW
Diagn Cytopathol; 1996 Nov; 15(4):292-5. PubMed ID: 8982583
[TBL] [Abstract][Full Text] [Related]
11. Expression of AgNORs in serous ovarian tumors.
Trabucco S; Varcaccio-Garofalo G; Botticella MA; De Stefano R; Capursi T; Resta L
Eur J Gynaecol Oncol; 1994; 15(3):222-9. PubMed ID: 7525292
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological significance of DEK overexpression in serous ovarian tumors.
Han S; Xuan Y; Liu S; Zhang M; Jin D; Jin R; Lin Z
Pathol Int; 2009 Jul; 59(7):443-7. PubMed ID: 19563407
[TBL] [Abstract][Full Text] [Related]
13. [Nucleolar organizers in the process of the malignant degeneration of bronchial epithelium].
Bolgova LS; Loboda VI; Tuganova TN
Tsitol Genet; 1998; 32(1):79-82. PubMed ID: 9695256
[TBL] [Abstract][Full Text] [Related]
14. Patterns of stromal invasion in ovarian serous tumors of low malignant potential (borderline tumors): a reevaluation of the concept of stromal microinvasion.
McKenney JK; Balzer BL; Longacre TA
Am J Surg Pathol; 2006 Oct; 30(10):1209-21. PubMed ID: 17001150
[TBL] [Abstract][Full Text] [Related]
15. [Assessment of the influence of chemotherapy on the nucleolar organizer regions (AgNORs) count in serous ovarian cancer cells].
Bieńkiewicz A; Gottwald L; Danilewicz M; Suzin J
Ginekol Pol; 2003 Sep; 74(9):677-82. PubMed ID: 14674107
[TBL] [Abstract][Full Text] [Related]
16. u-PA expression in benign, borderline and malignant ovarian tumors.
Kiziridou AD; Toliou T; Stefanou D; Agnantis N
Anticancer Res; 2002; 22(2A):985-90. PubMed ID: 12014682
[TBL] [Abstract][Full Text] [Related]
17. Fascin expression in serous tumors of ovary correlates with aggressiveness of malignancy.
Wen YH; Yee H; Goswami S; Shukla PS
Int J Gynecol Pathol; 2009 Mar; 28(2):187-92. PubMed ID: 19188814
[TBL] [Abstract][Full Text] [Related]
18. [Correlation between serious ovarian tumors and extra-ovarian peritoneal tumors of the same histology].
Kunz J; Rondez R
Praxis (Bern 1994); 1998 Feb; 87(6):191-8. PubMed ID: 9531813
[TBL] [Abstract][Full Text] [Related]
19. AgNORs count correlates better than grading with the effect of chemotherapy in serous ovarian cancer.
Gottwald L; Danilewicz M; Suzin J; Wójcik-Krowiranda K; Bieńkiewicz A
Pol J Pathol; 2003; 54(4):239-42. PubMed ID: 14998291
[TBL] [Abstract][Full Text] [Related]
20. Serous tumours of low malignant potential (serous borderline tumours): moving toward détente.
Longacre TA; Kempson RL; Hendrickson MR
Histopathology; 2005 Sep; 47(3):315-8. PubMed ID: 16115233
[No Abstract] [Full Text] [Related]
[Next] [New Search]
